Novel adjuvant compositions

Details for Australian Patent Application No. 2009263759 (hide)

Owner Pfizer Inc.

Inventors Zhang, Shucheng; Krebs, Richard Lee; Bagi, Cedo Martin; Dominowski, Paul Joseph; Yancey Jr., Robert John; Thompson, James Richard; Childers, Tedd Alan; Mannan, Ramasamy Mannar; Olsen, Mary Kathryn; Weeratna, Risini Dhammika

Agent Spruson & Ferguson

Pub. Number AU-A-2009263759

PCT Pub. Number WO2009/156960

Priority 61/076,232 27.06.08 US; 61/214,557 24.04.09 US

Filing date 24 June 2009

Wipo publication date 30 December 2009

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/012 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/156960 Priority application(s): WO2009/156960

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009263774-Active nanocomposite materials and production method thereof

2009263748-Tracheostomy tube butterfly flange